Transcription profiling of human HEL cells treated with either 5 uM of JI1 or 10 uM of Erlotinib reveal growth of leukemic Jak2-V617F positive cells is mutually suppressed by Jak inhibitors and Erlotinib through distinct mechanisms.
收藏官方服务：
资源简介：
Transcription profiling of human HEL cells treated with either 5 uM of JI1 or 10 uM of Erlotinib reveal growth of leukemic Jak2-V617F positive cells is mutually suppressed by Jak inhibitors and Erlotinib through distinct mechanisms.
创建时间：
2009-08-10
